Skip to main content

Table 5 Summary of multivariate analysis of factors in patients with N1 disease

From: Involvement of both Cervical Lymph Nodes and Retropharyngeal Lymph Nodes has prognostic value for N1 patients with Nasopharyngeal Carcinoma

Endpoint

Factor

B

P value

Exp (B)

95% CI for Exp (B)

DMFS

Both CLNs and RLNs involvement

-1.498

0.019

0.224

0.064-0.783

T stage

-1.374

0.005

0.253

0.096-0.666

Technique of radiotherapy

0.978

0.035

2.660

1.072-6.603

Sex

1.310

0.081

3.705

0.853-16.093

PFS

Both CLNs and RLNs involvement

-1.179

0.019

0.307

0.115-0.825

T stage

-1.046

0.010

0.351

0.159-0.776

Technique of radiotherapy

0.773

0.054

2.167

0.988-4.751

LRFS

Both CLNs and RLNs involvement

-1.002

0.051

0.367

0.134-1.003

 

T stage

-0.671

0.129

0.511

0.215-1.215

  1. Bold numbers, indicated there was statistically significant difference (p value < 0.05).
  2. RLN indicates retropharyngeal lymph node.
  3. CLN indicates cervical lymph node.
  4. LRFS, DMFS, PFS indicate for local-regional recurrence-free survival, distant metastasis-free survival and progression-free survival.